Model Release
OpenAI Unveils GPT-Rosalind for Pandemic Preparedness
OpenAI has launched the Rosalind Biodefense program, offering its life sciences AI model to government partners and developers to enhance pandemic readiness.
OpenAI has launched the Rosalind Biodefense program, providing selected developers and government partners access to GPT-Rosalind, a life sciences AI model introduced in April 2026. This model is designed to reason about molecules, proteins, genes, and disease biology more effectively than standard GPT models. The initiative aims to help researchers accelerate the transition from hypothesis to experiment, strengthening biodefense and pandemic preparedness. OpenAI, along with Anthropic and other AI researchers, has repeatedly warned about the risks of AI-driven bioweapons. The program covers access costs and supports vetted developers creating AI applications for early warning systems, diagnostics, and vaccine development. Early partners include the Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, and the vaccine initiative CEPI. Fourth Eon and SecureDNA are using the model for DNA screening. The program builds on existing safety measures, allowing academic, nonprofit, government-affiliated, and small-to-midsized teams with clear public benefit goals to apply. OpenAI is seeking projects that use AI to accelerate or scale defensive research, such as literature synthesis, protocol design, model-building, data harmonization, simulation, or decision support. *Source: [thedecoder](https://the-decoder.com/openai-is-giving-away-its-life-sciences-ai-model-to-help-governments-prepare-for-the-next-pandemic/)*
Key points
- OpenAI launched the Rosalind Biodefense program to provide access to GPT-Rosalind for government partners and developers.
- GPT-Rosalind is a life sciences AI model introduced in April 2026 that reasons about molecules, proteins, genes, and disease biology better than regular GPT models.
- The program aims to help researchers move faster from hypothesis to experiment and strengthen biodefense and pandemic preparedness.
- OpenAI, along with Anthropic and other AI researchers, has repeatedly warned about the risks of AI-driven bioweapons.
- The program covers access costs and supports vetted developers creating AI applications for early warning systems, diagnostics, and vaccine development.
- Early partners include the Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, and the vaccine initiative CEPI.
- Fourth Eon and SecureDNA are using the model for DNA screening.